DNA methylation is differentially associated with environmental cadmium exposure based on sex and smoking status  by Virani, Shama et al.
lable at ScienceDirect
Chemosphere 145 (2016) 284e290Contents lists avaiChemosphere
journal homepage: www.elsevier .com/locate/chemosphereDNA methylation is differentially associated with environmental
cadmium exposure based on sex and smoking status
Shama Virani a, Katie M. Rentschler a, Muneko Nishijo b, Werawan Ruangyuttikarn c,
Witaya Swaddiwudhipong d, Niladri Basu e, Laura S. Rozek a, f, *
a Department of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, USA
b Department of Public Health, Kanazawa Medical University, Uchinada, Ishikawa, Japan
c Department of Forensic Science, Chiang Mai University, Chiang Mai, Thailand
d Department of Community and Social Medicine, Mae Sot General Hospital, Tak, Thailand
e Faculty of Agricultural and Environmental Sciences, McGill University, Montreal, Quebec, Canada
f Department of Otolaryngology, University of Michigan, Ann Arbor, MI, USAh i g h l i g h t s Cd is associated with MGMT, MT2A, DNMT3B, and LINE-1 methylation in a sex-speciﬁc manner.
 Upon subanalysis, these associations persisted, but separated by smoking status.
 MGMT hypomethylation is associated with increasing body burden of Cd in nonsmokers.
 LINE-1, MT2A and DNMT3B methylation are associated with Cd in smokers.a r t i c l e i n f o
Article history:
Received 19 May 2015
Received in revised form
20 October 2015
Accepted 28 October 2015
Available online 11 December 2015
Handling Editor: Andreas Sjodin
keywords:
Environment
Cadmium
DNA methylation
Epigenetics
Sex
SmokingAbbreviations: Cd, cadmium; UCd, urinary cadmiu
* Corresponding author. 1415 Washington Heights
ences, 6630 SPH, Ann Arbor, MI, 48109-2029, USA.
E-mail address: rozekl@umich.edu (L.S. Rozek).
http://dx.doi.org/10.1016/j.chemosphere.2015.10.123
0045-6535/© 2015 The Authors. Published by Elseviera b s t r a c t
The adverse health effects of cadmium (Cd) are well known in human populations; however, much of
what is known about biological mechanisms of Cd comes from in vitro and animal studies. The adverse
health outcomes due to high levels of Cd exposure in the population of Mae Sot, Thailand have been
extensively characterized. Here, for the ﬁrst time, this population is being studied in an epigenetic
context. The objective of this study was to characterize the association between DNA methylation
markers and Cd exposure, taking into account sex and smoking differences, in an adult population at an
increased risk of experiencing adverse health outcomes from high body burden of Cd. One hundred and
sixty-nine residents from known exposure areas of Mae Sot, Thailand and one hundred residents from
non-exposed areas nearby were surveyed in 2012. Urine and blood samples were collected for mea-
surement of urinary Cd (UCd) and DNA methylation of Cd-related markers (DNMT3B, MGMT, LINE-1,
MT2A). UCd levels were 7 times higher in the exposed compared to the unexposed populations
(exposed median: 7.4 mg/L, unexposed median: 1.0 mg/L, p < 0.001). MGMT hypomethylation was asso-
ciated with increasing levels of UCd in the total population. Sex-speciﬁc associations included MT2A and
DNMT3B hypomethylation in women and LINE-1 hypermethylation in men with increasing UCd. Upon
subanalysis, these associations separated by smoking status. In summary, environmental Cd exposure is
associated with gene-speciﬁc DNA methylation in a sex and smoking dependent manner.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).m; IQR, Interquartile range.
, Environmental Health Sci-
Ltd. This is an open access article u1. Introduction
Cadmium (Cd) is a biologically toxic transition metal found in
low levels in nature and high levels from anthropogenic sources
(Agency for Toxic Substances and Disease Registry (ATSDR), 2008;
World Health Organization (WHO), 2010). Non-occupational ex-
posures occur from tobacco smoke and ingestion of contaminatednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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osteomalacia, cardiovascular diseases, and multiple cancers
(ATSDR, 2008; WHO, 2010; International Agency for Research on
Cancer (IARC), 2012). Cd sequesters in the liver and kidney and
replaces calcium in bone (Limpatanachote et al., 2010; Liang et al.,
2012). Many studies have provided evidence linking Cd to the in-
duction of cancer (Benbrahim-Tallaa et al., 2007, 2009; Gallagher
et al., 2010) and the IARC has classiﬁed Cd as a Group 1 human
carcinogen (IARC, 2012).
Mae Sot District is located on Thailand's northwest border and is
an area of high Cd contamination due to a long-standing zinc mine.
Several subdistricts have Cd levels in soil and rice exceeding Thai
standards of 0.15 mg/kg of soil and 0.043 mg/kg of rice (Zarcinas
et al., 2004). These standards reﬂect levels at which human expo-
sure may result in adverse health effects (Pongsakul, 1999). Rice is a
dietary staple and farmed in contaminated soil; therefore, exposure
to Cd in this population is via ingestion of contaminated rice. A
study in Mae Sot in 2004 found a subset of residents with urinary
Cd (UCd) levels 5 mg/g creatinine to also have irreversible renal
dysfunction, indicated by clinical parameters of renal marker levels
(Swaddiwudhipong et al., 2007; Limpatanachote et al., 2010). UCd
levels above this level induce preclinical renal dysfunction; there-
fore, 5 mg/g creatinine has been deemed as a human exposure
standard by the WHO (WHO JEFCA, 2010).
Although the association between UCd and adverse health
outcomes is well-described (Aoshima,1987; Oh and Lim, 2006); the
mechanism by which Cd exerts its biologic effects is unclear. Cd
weakly binds to DNA, is indirectly genotoxic and poorly mutagenic,
indicating that it does not initiate disease through direct interaction
with DNA (Hartwig, 1994; Waalkes, 2000). A number of genes are
transcriptionally induced by Cd implicating exposure may initiate
disease through epigenetic (Huang et al., 2008; Jiang et al., 2008;
Benbrahim-Tallaa et al., 2009). Cd has been shown to affect DNA
methylation, yet the direction of effect is unclear. Candidate gene
studies have identiﬁed DNA methylation markers associated with
Cd-induced kidney damage. Hypermethylation of tumor suppres-
sor RASAL1 and renal ﬁbrosis inhibitor KLOTHO was strongly asso-
ciated with blood and UCd levels as well as renal ﬁbrogenesis (Sun
et al., 2012; Zhang et al., 2013). Many studies have implicated
epigenetic changes in the process of Cd-mediated tumorigenesis
(Huang et al., 2001; Benbrahim-Tallaa et al., 2007). Increased DNA
methylation and DNMT3b enzyme activity were reported in human
lung ﬁbroblasts after twomonths of Cd exposure (Jiang et al., 2008).
Cd-induced malignant transformation of human prostate and
breast cell lines has been observed in vitro (Benbrahim-Tallaa et al.,
2007, 2009). Cd-induced gene-speciﬁc DNA hypermethylation has
been reported for genes involved in cell cycle regulation, DNA
repair, apoptosis and proliferation (Wang et al., 2012; Zhou et al.,
2012). Hypermethylation can prevent transcription of these genes
and promote initiation of disease. These studies show that Cd in-
duces epigenetic alterations, which may fall along the molecular
pathway of Cd exposure and adverse health outcomes.
Much of what we know about Cd-induced epigenetic changes
comes from animal models or in vitro studies. Only a few key
studies regarding methylation have been in human populations.
Hossein et al. showed that UCd was associated with LINE-1 hypo-
methylation and decreased DNMT3b expression among women
(Hossain et al., 2012). Sanders et al. showed patterns of Cd-
associated methylation that were distinct from cotinine-
associated methylation in newborns and mothers (Sanders et al.,
2014). Additionally, sex differences in body burden, health out-
comes and epigenetic alterations have been reported in response to
Cd exposure. Here, we measured methylation in MT2A (Metal-
lothionein 2A),DNMT3B (DNAmethyltransferase 3B) andMGMT (O-
6-methylguanine DNA methyltransferase) genes, which have beenfound to be altered in the presence of Cd in animal models and
in vitro studies (Benbrahim-Tallaa et al., 2007; Arita and Costa,
2009; Hossain et al., 2012; Zhou et al., 2012). Methylation of
LINE-1, a retrotransposon, was measured as a proxy for genomic
stability (Kippler et al., 2013; Sanders et al., 2014). Because body
burden of Cd increases with age and high body burden is known to
be associated with adverse health outcomes (Zhang et al., 2013),
the objective of this study was to determine the sex- and smoking-
speciﬁc associations between UCd and methylation of selected
genes in an adult population to clarify the role of gene methylation
in Cd exposure.2. Materials & methods
2.1. Study population
The study area and subjects have been previously described
and extensively characterized (Nambunmee et al., 2010;
Ruangyuttikarn et al., 2013). Brieﬂy, the study participants con-
sisted of 169 residents living in Mae Ku, Phra Thad Padang, and
Mae Tao, known polluted areas of Mae Sot, and 100 participants
living the Mae Kasa subdistrict, a non-contaminated area of Mae
Sot (Simmons et al., 2005). These areas are all rural, with similar
socioeconomic environments. Subjects from polluted areas aged
40 years and with urinary Cd levels 5 mg/g creatinine in the
2007 survey were included in this study (Nambunmee et al.,
2010). Exposed residents were 5-year age-matched to residents
from the Mae Kasa subdistrict. Each participant was consented
and interviewed by trained nurses. The research ethical commit-
tee of the Faculty of Medicine, Chiang Mai University approved
this study. (Approval No. 004/2012).2.2. Sample collection and processing
Twenty-ﬁve mL of morning urine was collected from each
participant in Cd-free polyethylene containers and stored
at 20 C. Fasting venous whole blood with EDTA and urine sam-
ples were frozen and transported on dry ice to the University of
Michigan for DNA extraction and Cd measurements.2.3. Urinary cadmium measurement
A refractometer determined speciﬁc gravity of each sample
(PAL-10S, Atago Inc.). UCd was measured at the Michigan Depart-
ment of Community Health as part of the U.S. Centers for Disease
Control (CDC) Laboratory Response Network Program. Brieﬂy, urine
samples were diluted 1:10 with a diluent composed of 2.0% nitric
acid, internal standards and 0.05% Triton X; and Cd concentrations
were determined using ICP-MS (DRCII, PerkinElmer, USA). The
analytical accuracy using QMEQAS08U urinary standard reference
material (Institut national de sante publique du Quebec, INSPQ)
was 101.1% (n ¼ 8). All samples were above the analytical detection
limit of 0.15 mg/L.2.4. DNA preparation
DNA was extracted from 300 mL of whole blood using the
QiaAMP DNA Mini Kit (Qiagen, Valencia, CA, USA). DNA concen-
tration was quantiﬁed using the Nanodrop (ThermoScientiﬁc,
Wayne, MI, USA), and stored at 20 C. Sodium bisulﬁte modiﬁ-
cation was performed on 500 ng of genomic DNA using the EpiTect
Bisulﬁte Kit (Qiagen, Valencia, CA, USA) according to the manu-
facturer's protocol.
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Methylation assays for MT2A, DNMT3B and MGMT, were
designed using PyroMark Assay Design 2.0. LINE-1methylationwas
measured using a previously published assay (Yang et al., 2004).
Bisulﬁte singleplex PCR ampliﬁcation was performed using Fast-
Start Taq Polymerase (Roche Diagnostics, Indiana, USA)with primer
concentrations of 0.2 mM and 10 ng/mL of bisulﬁte-converted DNA.
Fifteen microliters of PCR product was combined with sequencing
primer and methylation analysis was conducted using the Pyro-
mark™MD System (Biotage) according to manufacturer's protocol
(PyroGold reagents). Four bisulﬁte and four pyrosequencing con-
trols were generated by mixing unmethylated and methylated
control DNA (genomic: EpigenDX; bisulﬁte-converted: Epitect) to
obtain controls with 0%, 30%, 60% and 100% methylation. Each
sample plate was run with all controls. If methylation values of
controls were incorrect, all samples on plate were re-run. Mea-
surement of all samples for every methylation marker was not
possible due to insufﬁcient quantity of extracted DNA.Table 1
Descriptive statistics of study population.
Unexposed Exposed2.6. Statistical analysis
Correlations between creatinine (Cr)-adjusted, speciﬁc gravity
(SG)-adjusted and unadjusted values were calculated using the
Spearman method. UCd levels were adjusted by speciﬁc gravity to
account for all dilution-related variation (Suwazono et al., 2005).
Urinary markers were standardized to the median speciﬁc gravity
of the control population with the following formula: Cc ¼ C[(1.017
- 1)/SG - 1)], where Cc is the SG-corrected UCd, C is the observed Cd
level, 1.017 is the median SG of the unexposed population, and SG is
the speciﬁc gravity of the individual's urine sample (Meeker et al.,
2009). Chi-squared and ManneWhitney tests were used to
compare exposed and unexposed populations. Statistical signiﬁ-
cance was deﬁned when p < 0.05.
Linear regression models were used to determine the associa-
tions between UCd and each methylation marker. Methylation
changes were standardized to an interquartile range (IQR) increase
in UCd levels. Methylation units were in 1% increments. Due to
departures from normality, UCd and all methylation markers were
log-transformed for regression analysis. Models were interpreted
as percent increases in predictor associatedwith percent changes in
outcome. Age, smoking status and occupationwere associated with
UCd levels and included as covariates. Because methylation was
measured inwhite blood cell DNA, all models were re-run adjusting
for white blood cell count. There were no differences in results, and
white blood cell count was not included in ﬁnal models as it was
not associated with UCd and methylation markers.
Women have higher body burden of Cd regardless of exposure;
therefore, models were stratiﬁed by sex. All models were repeated
within nonsmokers and smokers separately. Smokers included
both former and current smokers.
R-statistical software was used for all analyses (R version 3.0.1).
(n ¼ 100) (n ¼ 169)
Mean (SD) Mean (SD) p-value*
Age (years) 61.0 (11.5) 61.2 (11.8) 0.93
Median (IQR) Median (IQR) p-value*
UCd (mg/L) 1.0 (0.65, 1.60) 7.4 (4.4, 10.2) <0.001
LINE-1 (%) 80.5 (79.0, 81.1) 80.2 (79.4, 81.1) 0.78
MT2A (%) 23.2 (20.9, 25.8) 23.1 (20.8, 25.0) 0.38
DNMT3B (%) 1.4 (1.1, 1.9) 1.4 (1.2, 1.9) 0.78
MGMT (%) 2.3 (1.8, 3.1) 1.7 (1.4, 2.1) <0.001
* p-values from ManneWhitney test; Abbreviations: UCd (urinary cadmium); n
(number of subjects); SD (standard deviation); IQR (Interquartile Range).3. Results
3.1. High correlation among UCd measurements with different
correction methods
Correlation coefﬁcients for unadjusted UCd and SG-adjusted
UCd and for SG-adjusted and Cr-adjusted UCd were similar
(rho ¼ 0.95, p < 0.0001). The correlation coefﬁcient for unadjusted
UCd and Cr-adjusted UCd was slightly lower (rho ¼ 0.87,
p < 0.0001).3.2. Differences by exposure group and sex
Median levels of UCd were seven times higher in the exposed
population than the unexposed population (unexposed [median
(range)]: 1.0 mg/L (0.65, 1.60); exposed: 7.4 mg/L (4.4, 10.2);
p < 0.001).MGMTwas the only methylation marker that differed by
exposure group. Methylation of MGMT was signiﬁcantly lower in
the Cd exposed population as compared to the unexposed popu-
lation (p < 0.001) (Table 1). The proportion of regular smokers was
highest in the Cd exposed population, of which 66% were male;
whereas the unexposed population had similar proportions of
never, former and regular smokers (Table 2). The proportion of
women was higher in the nonsmoking (83%) compared to the
smoking group (31%). The majority of the unexposed population
was farmers (74%) compared to only ﬁfty percent in the Cd exposed
population.
We compared men and women within each exposure group to
determine sex-speciﬁc differences. Within the unexposed group,
women had signiﬁcantly higher levels of UCd and DNMT3B
methylation compared to men. However, within the Cd exposed
group, women had signiﬁcantly lower levels of UCd and LINE-1
methylation compared to men (Table 3).
We then compared exposure groups to determine exposure-
speciﬁc differences by sex. These comparisons revealed exposed
men and women had signiﬁcantly higher levels of UCd and lower
MGMT methylation levels compared to their unexposed counter-
parts. Additionally, exposed men had signiﬁcantly higher DNMT3B
methylation than unexposed men.
3.3. Urinary cadmium associated with methylation markers in sex-
speciﬁc manner
Regression analyses adjusted for age, smoking status, and
occupation showed distinct associations of methylation markers
with UCd (Fig. 1). In the total population, MGMT methylation
decreased by 16.6% with an IQR increase in UCd levels (p < 0.001).
Among men, MGMT methylation decreased by 24.7% and LINE-1
methylation increased by 1% with an IQR increase in UCd
(p ¼ 0.003; p ¼ 0.04). Among women, DNMT3B methylation
decreased by 8.5% andMT2Amethylation decreased by 7.4%with an
IQR increase in UCd (p¼ 0.04; p¼ 0.03). Methylationmarkers were
not correlated with each other.
3.4. Methylation markers are differentially associated with UCd
based upon smoking status
UCd levels between smokers (n¼ 167) (median (95%CI): 4.4 mg/L
(1.3, 9.0)) and nonsmokers (n¼ 102) (median (95%CI): 3.4 mg/L (1.5,
Table 2
Demographics of study population.
All
(n ¼ 269)
Male
(n ¼ 133)
Female
(n ¼ 136)
Unexposed
N (%)
Exposed
N (%)
p* Unexposed
N (%)
Exposed
N (%)
p* Unexposed
N (%)
Exposed
N (%)
p*
Smoking
Never 36 (36) 66 (39.1) 0.03 6 (12) 11 (13.3) 0.03 30 (60) 55 (64) 0.64
Former 33 (33) 32 (18.9) 21 (42) 17 (20.5) 12 (24) 15 (17.4)
Regular 31 (31) 71 (42.0) 23 (46) 55 (66.3) 8 (16) 16 (18.6)
Drinker
Never 50 (50) 82 (48.5) 0.23 6 (12) 19 (22.9) 0.05 44 (88) 63 (73.3) 0.13
Former 26 (26) 33 (19.5) 23 (46) 22 (26.5) 3 (6) 11 (12.8)
Regular 24 (24) 54 (32.0) 21 (42) 42 (50.6) 3 (6) 12 (14)
Occupation
Agriculture 74 (74) 85 (50.3) <0.001 36 (72) 51 (61.4) 0.29 38 (76) 34 (39.5) <0.001
Other 26 (26) 84 (49.7) 14 (28) 32 (38.6) 12 (24) 52 (60.5)
*Chi-squared test; N ¼ number of subjects.
Table 3
Descriptive statistics of study population by sex.
Unexposed
(n ¼ 100)
Exposed
(n ¼ 169)
Male
(n ¼ 50)
Female
(n ¼ 50)
p-valuea Male
(n ¼ 83)
Female
(n ¼ 86)
p-valueb p-valuec (M) p-valued (F)
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age (years) 62.5 (12.1) 59.6 (10.9) 0.19 62.7 (11.7) 59.7 (11.8) 0.09 0.91 0.99
Median (IQR) Median (IQR) Median (IQR) Median (IQR)
UCd (mg/L) 0.9 (0.5, 1.2) 1.4 (0.9, 2.0) <0.001 8.0 (5.2, 10.5) 6.4 (3.6, 9.5) 0.04 <0.001 <0.001
LINE-1 (%) 80.6 (79.0, 81.1) 80.4 (79.0, 81.2) 0.80 80.4 (79.7, 81.4) 79.7 (78.9, 80.7) 0.001 0.33 0.20
MT2A (%) 22.8 (20.7, 24.9) 23.7 (21.5, 26.2) 0.13 22.7 (20.7, 24.4) 23.5 (21.0, 25.5) 0.33 0.96 0.23
DNMT3B (%) 1.3 (0.9, 1.8) 1.7 (1.3, 2.1) 0.008 1.5 (1.2, 1.9) 1.4 (1.2, 1.9) 0.66 0.03 0.07
MGMT (%) 2.4 (2.0, 3.4) 2.2 (1.7, 2.7) 0.22 1.6 (1.3, 2.2) 1.7 (1.4, 2.0) 0.91 0.0002 0.003
Abbreviations: UCd (urinary cadmium); n (number of subjects); SD (standard deviation); IQR (Interquartile Range); M (males); F (females).
p-values are all from ManneWhitney tests for comparisons between males and females within the aunexposed group, bexposed group, and between exposure groups within
cmales and dfemales.
Fig. 1. Regression analysis. Total population (magenta); Nonsmokers only (light blue, dashed); Smokers only (dark blue, long dash); Lines represent standardized beta es-
timate and 95% conﬁdence interval of percent change in methylation (y-axis) for every unit increase in IQR of UCd. Smokers included both current and former smokers. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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were exposed had signiﬁcantly higher UCd levels and lowerMGMT
methylation than their unexposed counterparts (Supplementary
Table 1S).
Regression models revealed signiﬁcant hypomethylation of
MGMT for all non-smokers and non-smoking men and women
separately (Fig. 1, Supplementary Table 2S). This was similar to the
results observed in the total population, although withinnonsmokers, hypomethylation of MGMT in women reached statis-
tical signiﬁcance. Speciﬁcally, an IQR increase in UCd was associ-
ated with a 25.6% decrease in MGMT methylation among all
nonsmokers, whereas MGMT decreased by 31.9% and 7.2% in
nonsmoking men and nonsmoking women, respectively. Associa-
tions of other methylation markers that were seen in the total
population were not found to be signiﬁcant within nonsmokers.
In contrast, regression analysis within smokers showed separate
S. Virani et al. / Chemosphere 145 (2016) 284e290288associations by sex (Fig. 1). An IQR increase in UCd was associated
with a 0.9% decrease in LINE-1methylation inmen only; whereas in
women, this was associated with an 18.1% decrease in both MT2A
and DNMT3B methylation (Fig. 1).
4. Discussion
The toxic effects of environmental Cd exposure were studied
with the outbreak of ItaieItai disease in Japan in response to
extreme Cd exposure from ingestion of contaminated rice. Cd has
since been shown to have a variety of adverse effects on human
health including proximal tubular renal dysfunction, bone disor-
ders, and cancer (Simmons et al., 2005; Limpatanachote et al., 2010;
Satarug et al., 2010; Swaddiwudhipong et al., 2010). However, the
pathway by which Cd induces these health outcomes is unknown.
Our study shows the expected differences in UCd between
exposure groups. The exposed group had signiﬁcantly higher levels
of UCd compared to the unexposed group. Although the unexposed
population had detectable amounts of UCd, body burden of Cd in-
creases with age and these levels are consistent with unexposed
populations above age 40 from similar geographic areas. Residents
over the age of 50 living in non-polluted areas in Japan had urinary
Cd levels of 1.6 mg/L in men and 1.8 mg/L inwomen (Suwazono et al.,
2000). Residents with a median age of 50 living in non-polluted
areas of China had urinary levels of 2.5 mg/g creatinine (Zhang
et al., 2013). These values are higher than our unexposed popula-
tion considering the correlation between creatinine-adjusted and
speciﬁc gravity-adjusted UCd measurements. Therefore, our un-
exposed group provides a good control to measure Cd exposure in
demographically similar populations.
We report the expected sex-speciﬁc differences in UCd within
exposure groups. Women, especially those with low iron stores,
tend to have higher body burdens of Cd as compared to men,
regardless of exposure levels (Vahter et al., 2002; Satarug et al.,
2004). This is seen in our study as women living in the unex-
posed area had higher levels of UCd compared to men in the same
area. However, within those living in high Cd-exposed areas,
women had lower levels of UCd compared to men living in the
same area. The large proportion of male smokers living in Cd-
exposed areas may explain this observation. UCd measurements
are representative of total body burden from all exposure sources,
including both ingestion of contaminated rice and inhalation of
tobacco smoke. Toxicologically, Cd absorption through lungs is
much higher compared to that of the gut (IARC, 1993). Therefore,
exposed men may have a larger body burden due to a combination
of exposures.
We also report differences in methylation markers across
exposure groups for each sex. Expectedly, exposedmen andwomen
had higher UCd levels than their unexposed counterparts; however,
they had lower levels of MGMT methylation. MGMT hypo-
methylation was associated with an increase in UCd in the total
population and men alone. Although MGMT methylation was not
signiﬁcant in women, the trend was similar. MGMT is involved in
DNA repair from oxidative stress. Cd is hypothesized to induce toxic
effects via induction of reactive oxidative species (Khojastehfar
et al., 2015; Matovic et al., 2015). Reduced methylation of this
gene promoter may reﬂect induction to repair damage from
oxidative stress due to Cd exposure. As a biomarker, methylation of
this gene may be used as an indicator of oxidative stress in Cd-
exposed populations.
LINE-1 hypermethylation was associated with an increase in
UCd in men. This corroborates previous literature showing men
tend to have higher methylation of LINE-1, even in the presence of
Cd exposure (Zhang et al., 2011). However, this association is
opposite to that found in a previous study, although it's likely due tothe fact that the subjects in that study were all women with much
lower levels of Cd exposure (Hossain et al., 2012). Our ﬁndings
validate previous evidence of LINE-1 hypermethylation in newborn
boys prenatally exposed to Cd (Kippler et al., 2013), and extend this
evidence to an adult male population.
MT2A hypomethylation was associated with increasing UCd in
women only. This ﬁnding is new and has not been reported pre-
viously in the literature. MT2A encodes metallothionein, a protein
that binds free Cd and sequesters it in the liver and kidney. Women
tend to have higher body burden of Cd compared to men due to
higher gut absorption rates (Nishijo et al., 2004) and, this may point
to a potential mechanism of increased MT2A expression by which
womenmay sequester larger amounts for longer periods of time. As
a biomarker, MT2A methylation may be useful in determining
actual body burden of Cd in women.
Our regression analysis found that DNMT3B is inversely associ-
ated with UCd in women. DNMT3B encodes a DNA methyl-
transferase involved in de novo methylation. Previous studies
evaluated the relationship between DNMT3b protein expression
and Cd, ﬁnding expression to be inversely associated with Cd in
women and positively associated with Cd in prostate and lung cell
lines (Takiguchi et al., 2003; Benbrahim-Tallaa et al., 2007; Jiang
et al., 2008; Hossain et al., 2012). Our ﬁnding of hypomethylation of
DNMT3Bwith increasing levels of UCd in women is consistent with
DNMT3b protein overexpression. However, we observed that both
men and women with higher levels of UCd exhibited higher levels
of methylation of DNMT3B, suggesting reduced expression. These
contrasting ﬁndings are indicative that DNMT3B methylation may
be a marker of a speciﬁc type of exposure to Cd. UCd is a measure of
total body burden and can reﬂect multiple routes of Cd exposure,
such as smoking and diet, which may have distinct biological ef-
fects. Recently, cotinine-associated methylation patterns have been
shown to be distinct from Cd-associated patterns (Sanders et al.,
2014). This is likely due to the large number of toxic compounds
found in cigarette smoke that can alter methylation (ATSDR, 2008)
as well as the mixture of metals likely found in Mae Sot. To address
this, we conducted a subanalysis within smokers and nonsmokers
to validate our ﬁndings.
Stratiﬁcation by smoking status revealed differential associa-
tions between methylation markers and UCd. In nonsmokers,
MGMT hypomethylation was associated with increasing levels of
UCd. This association persisted in nonsmoking men and women
separately, although therewere only 17 nonsmokingmen. However
within smokers, LINE-1 hypermethylation was associated with
increasing UCd in men only, while MT2A and DNMT3B hypo-
methylationwas associated with increasing UCd inwomen only. All
these associations were found in the total population and separate
out by smoking status. Although samples sizes are small, especially
by sex, these ﬁndings suggest that speciﬁc methylation markers
may be important depending upon the source of Cd exposure. LINE-
1, MT2A and DNMT3B seem to be important in tobacco-related Cd
exposure, whileMGMTmay play a role in other routes of exposure,
including dietary intake.
The ﬁndings presented here are critical in contributing to future
epigenetic studies on Cd exposure in humans, which should be
attentive to addressing the limitations of the present study. The
subset analysis of smoking was useful in identifying markers that
may be indicators of dietary versus tobacco exposures. However,
stratiﬁcation by sex within exposure and smoking groups led to
small sample sizes, limiting generalizability of the results. Addi-
tionally, our exposed smokers were subjected to Cd via both to-
bacco and diet. Our intent in conducting these subanalyses was to
provide preliminary evidence of differential methylation by
smoking. Nevertheless, larger studies separating smokers and
nonsmokers by sex and type of exposure in Cd-exposed
S. Virani et al. / Chemosphere 145 (2016) 284e290 289populations are necessary to support the evidence presented here.
Future studies may be able to achieve a large enough sample size
and include cotinine measurements for tobacco exposure to sepa-
rate the effects of multiple Cd sources.
Gene expression was not measured in this study; however, the
methylation markers presented here are intended as molecular
biomarkers of Cd exposure rather than indicators of mechanisms.
Environmental exposures may not always be reﬂective of body
burden since the exposure must be inhaled/ingested to contribute
to internal dose. These methylation markers are associated with
UCd, and can be used to assess dysfunction preceding a Cd-
associated adverse health outcome.
It is well known that exposure to Cd likely includes co-
exposures to other heavy metals commonly found with Cd, such
as arsenic, copper and lead, are also associated with epigenetic
changes (Cheng et al., 2012); however, these were not measured in
this study. Our current study identiﬁed methylation markers rele-
vant to Cd exposure and future studies measuring multiple metals
for association with these markers in this population are currently
underway.
5. Conclusions
Our study takes advantage of an extensively characterized
population in Mae Sot, Thailand with a wide range of urinary Cd
levels to validate DNA methylation markers of Cd exposure in a
human population. DNMT3B,MGMT, LINE-1 andMT2Awere chosen
based on in vitro and in vivo evidence of their association with Cd.
This is the ﬁrst study to be able to look at such exposure ranges
within the context of DNAmethylation in a population-based study.
Studies such as these are a logical ﬁrst step to identifying the
mechanisms of Cd toxicity and may identify useful biomarkers that
indicate underlying health consequences of Cd exposure.
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